$BWIN
Baldwin Insurance Group, Inc. Stock $bwin

$bwin Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000178175523000042 Filed on November 07, 2023

Income Statement

Concept	2023 Q3	2022 Q3
Revenue	$306.3M	$259.4M
YoY Change	18.09%	91.34%
Cost Of Revenue	$220.5M	$195.9M
YoY Change	12.55%	95.76%
Gross Profit	$85.80M	$63.45M
YoY Change	35.23%	78.85%
Gross Profit Margin	28.01%	24.46%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.453M	$1.216M
YoY Change	19.49%	61.49%
% of Gross Profit	1.69%	1.92%
Operating Expenses	$85.70M	$93.30M
YoY Change	-8.15%	78.47%
Operating Profit	$86.00K	-$29.86M
YoY Change	-100.29%	73.75%
Interest Expense	-$30.60M	-$20.77M
YoY Change	47.36%	199.22%
% of Operating Profit	-35581.4%
Other Income/Expense, Net	-$31.93M	-$16.85M
YoY Change	89.48%	127.18%
Pretax Income	-$31.85M	-$46.71M
YoY Change	-31.82%	89.86%
Income Tax	$161.0K	$0.00
% Of Pretax Income
Net Earnings	-$17.63M	-$24.79M
YoY Change	-28.9%	87.66%
Net Earnings / Revenue	-5.76%	-9.56%
Basic Earnings Per Share	-$0.29	-$0.43
Diluted Earnings Per Share	-$0.29	-$0.43
COMMON SHARES
Basic Shares Outstanding	60.55M shares	57.28M shares
Diluted Shares Outstanding	60.55M shares	57.28M shares

Balance Sheet

Concept	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.00M	$158.6M
YoY Change	-50.19%	-57.64%
Cash & Equivalents	$78.97M	$158.6M
Short-Term Investments
Other Short-Term Assets	$127.8M	$104.3M
YoY Change	22.49%	97.49%
Inventory
Prepaid Expenses
Receivables	$595.4M	$446.1M
Other Receivables	$0.00	$1.844M
Total Short-Term Assets	$802.1M	$710.9M
YoY Change	12.83%	7.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.38M	$24.50M
YoY Change	-0.5%	77.85%
Goodwill	$1.422B	$1.421B
YoY Change	0.06%	60.5%
Intangibles	$1.045B	$1.118B
YoY Change	-6.56%	71.3%
Long-Term Investments
YoY Change
Other Assets	$41.74M	$39.89M
YoY Change	4.63%	91.35%
Total Long-Term Assets	$2.621B	$2.701B
YoY Change	-2.97%	71.78%
TOTAL ASSETS
Total Short-Term Assets	$802.1M	$710.9M
Total Long-Term Assets	$2.621B	$2.701B
Total Assets	$3.423B	$3.412B
YoY Change	0.33%	52.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$567.9M	$417.5M
YoY Change	36.04%	97.84%
Accrued Expenses	$13.07M	$11.86M
YoY Change	10.18%	-76.14%
Deferred Revenue	$27.09M	$25.06M
YoY Change	8.12%	99.55%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.24M	$8.509M
YoY Change	20.38%	70.18%
Total Short-Term Liabilities	$798.5M	$573.3M
YoY Change	39.28%	49.39%
LONG-TERM LIABILITIES
Long-Term Debt	$1.294B	$1.338B
YoY Change	-3.31%	123.99%
Other Long-Term Liabilities	$241.0K	$330.0K
YoY Change	-26.97%	-90.06%
Total Long-Term Liabilities	$241.0K	$330.0K
YoY Change	-26.97%	-90.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$798.5M	$573.3M
Total Long-Term Liabilities	$241.0K	$330.0K
Total Liabilities	$2.350B	$2.188B
YoY Change	7.37%	95.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.4M	-$48.27M
YoY Change	215.74%	49.35%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$590.8M	$651.7M
YoY Change
Total Liabilities & Shareholders Equity	$3.423B	$3.412B
YoY Change	0.33%	52.81%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$17.63M	-$24.79M
YoY Change	-28.9%	87.66%
Depreciation, Depletion And Amortization	$1.453M	$1.216M
YoY Change	19.49%	61.49%
Cash From Operating Activities	-$12.63M	-$12.01M
YoY Change	5.14%	-46.32%
INVESTING ACTIVITIES
Capital Expenditures	$6.040M	-$6.835M
YoY Change	-188.37%	377.3%
Acquisitions
YoY Change
Other Investing Activities	-$310.0K	-$10.74M
YoY Change	-97.11%	-94.48%
Cash From Investing Activities	-$6.360M	-$17.57M
YoY Change	-63.8%	-91.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	480.0K	-3.731M
YoY Change	-112.87%	-101.03%
NET CHANGE
Cash From Operating Activities	-12.63M	-12.01M
Cash From Investing Activities	-6.360M	-17.57M
Cash From Financing Activities	480.0K	-3.731M
Net Change In Cash	-18.51M	-33.31M
YoY Change	-44.44%	-122.9%
FREE CASH FLOW
Cash From Operating Activities	-$12.63M	-$12.01M
Capital Expenditures	$6.040M	-$6.835M
Free Cash Flow	-$18.67M	-$5.177M
YoY Change	260.63%	-75.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Assets Current AssetsCurrent	802123000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	772399000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24378000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25405000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	96465000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	41738000	usd
CY2023Q3	us-gaap	Assets Assets	3423498000	usd
CY2022Q4	us-gaap	Assets Assets	3462182000	usd
CY2023Q3	brp	Premiums Payable To Insurance Companies PremiumsPayableToInsuranceCompanies	502081000	usd
CY2022Q4	brp	Premiums Payable To Insurance Companies PremiumsPayableToInsuranceCompanies	471294000	usd
CY2023Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	65855000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	53927000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	131418000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	125743000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1525000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1525000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	97620000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	46717000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	798499000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	699206000	usd
CY2023Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	324000000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	505000000	usd
CY2023Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	969711000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	809862000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	175657000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	220219000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	81510000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87692000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	241000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	164000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2349618000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2322143000	usd
CY2023Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	333000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	487000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	734676000	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	195920000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	676659000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	522518000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	47165000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	47212000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	1453000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1216000	usd
	us-gaap	Depreciation Depreciation	4250000	usd
	us-gaap	Depreciation Depreciation	3309000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	306184000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	289223000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	946733000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	699354000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	86000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-29855000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12826000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	35322000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30580000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-20766000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-87600000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-45748000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1351000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3914000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-193000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25151000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31931000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16852000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87793000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20597000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31845000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46707000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-100619000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14725000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	161000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	904000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-32006000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-46707000	usd
	us-gaap	Profit Loss ProfitLoss	-101523000	usd
	us-gaap	Profit Loss ProfitLoss	14725000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-14377000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-21914000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32006000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-46707000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-101523000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14725000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-14377000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-21914000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-45865000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17629000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24793000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56430095	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60549080	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57282132	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59791435	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59895371	shares
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15400000	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	3356000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	387919000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-407466000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4447000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	7893000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	408000	usd
	brp	Proceeds From Collection Of Stock Subscription Receivable ProceedsFromCollectionOfStockSubscriptionReceivable	42000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-36077000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	230471000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227737000	usd
	us-gaap	Interest Paid Net InterestPaidNet	77455000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1208000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4391000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	699000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	25.34
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	88586000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	45935000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1044824000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1099918000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1421849000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1422060000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	742553000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	704291000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152422000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96764000	usd
CY2023Q3	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	0	usd
CY2022Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	42000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	590778000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	608104000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	482769000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	531448000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1073547000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1139552000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3423498000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3462182000	usd
CY2023Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	306270000	usd
CY2022Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	259368000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	933907000	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	220469000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	69505000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	59912000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13914000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	21695000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	55065000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-10809000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-45865000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8007000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17629000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-24793000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55658000	usd
	us-gaap	Net Income Loss NetIncomeLoss	6718000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60549080	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59791435	shares
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1096767000	usd
CY2023Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-32088000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8915000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	47000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1139552000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-101754000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	36115000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	408000	usd
	brp	Reduction Of Stockholders Notes Payable To Member Units ReductionOfStockholdersNotesPayableToMemberUnits	42000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1073547000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1259535000	usd
CY2022Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-46781000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2949000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7869000	usd
CY2022Q3	brp	Reduction Of Stockholders Notes Payable To Member Units ReductionOfStockholdersNotesPayableToMemberUnits	68000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1223640000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1187287000	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	14570000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4819000	usd
	brp	Reduction Of Stockholders Notes Payable To Member Units ReductionOfStockholdersNotesPayableToMemberUnits	156000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1223640000	usd
	us-gaap	Profit Loss ProfitLoss	-101523000	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	73755000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	55065000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	46637000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-489000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	25420000	usd
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	48943000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3577000	usd
	brp	Fair Value Adjustments Other FairValueAdjustmentsOther	797000	usd
	brp	Fair Value Adjustments Other FairValueAdjustmentsOther	369000	usd
	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	63367000	usd
	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	97126000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6294000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11087000	usd
	brp	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-7671000	usd
	brp	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	15076000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32793000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	70282000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4162000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	16992000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3740000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22799000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16653000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14157000	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	2118000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	791000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16948000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	26808000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	47218000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	88000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	512000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	269000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20000000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	170000000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	6815000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	6382000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1751000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	19587000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9393000	usd
	brp	Proceeds From Collection Of Stock Subscription Receivable ProceedsFromCollectionOfStockSubscriptionReceivable	156000	usd
	us-gaap	Interest Paid Net InterestPaidNet	41225000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1056000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	23444000	usd
	brp	Contingent Earnout Liabilities Assumed In Business Combinations And Asset Acquisitions ContingentEarnoutLiabilitiesAssumedInBusinessCombinationsAndAssetAcquisitions	723000	usd
	brp	Contingent Earnout Liabilities Assumed In Business Combinations And Asset Acquisitions ContingentEarnoutLiabilitiesAssumedInBusinessCombinationsAndAssetAcquisitions	16495000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1198000	usd
	brp	Right Of Use Assets Increased Through Lease Modifications And Reassessments RightOfUseAssetsIncreasedThroughLeaseModificationsAndReassessments	697000	usd
	brp	Right Of Use Assets Increased Through Lease Modifications And Reassessments RightOfUseAssetsIncreasedThroughLeaseModificationsAndReassessments	4732000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	245000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-211000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	3455000	usd
	brp	Equity Interest Issued In Business Combinations And Asset Acquisitions EquityInterestIssuedInBusinessCombinationsAndAssetAcquisitions	0	usd
	brp	Equity Interest Issued In Business Combinations And Asset Acquisitions EquityInterestIssuedInBusinessCombinationsAndAssetAcquisitions	4819000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	711000	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-07-01
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Significant accounting policies and estimates underlying the accompanying condensed consolidated financial statements include the application of guidance for revenue recognition; the valuation of acquired relationships and contingent consideration; impairment of long-lived assets and goodwill; share-based compensation related to performance-based restricted stock unit awards; and the valuation allowance for deferred tax assets.
CY2023Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	306270000	usd
CY2022Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	259368000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	933907000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	734676000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2023Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	327999000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	278023000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	27094000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30981000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	30600000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44903000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	27094000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30981000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16064000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14043000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13070000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	156054	shares
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24840000	usd
CY2022Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	16198000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	21669000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	11336000	usd
CY2023Q3	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	2666000	usd
CY2022Q3	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	3641000	usd
	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	9170000	usd
	brp	Capitalized Contract Cost Capitalized Amount CapitalizedContractCostCapitalizedAmount	10509000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1847000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1206000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	5180000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3212000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	25659000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	18633000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	25659000	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	18633000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48782000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13101000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	10243000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8509000	usd
CY2023Q3	brp	Deferred Consideration Payments DeferredConsiderationPayments	3471000	usd
CY2022Q4	brp	Deferred Consideration Payments DeferredConsiderationPayments	6840000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12694000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7366000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	131418000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	125743000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	19700000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	21300000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2561000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	10243000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10243000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	10243000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	968008000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1001298000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	21344000	usd
CY2023Q3	us-gaap	Secured Debt SecuredDebt	979954000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1500000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1500000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3595303	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1585820	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	29.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1145017	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	25.82
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3880052	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	29600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	13900000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14600000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46600000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26100000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17629000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24793000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-55658000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6718000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60549000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57282000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59791000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56430000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17629000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24793000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-55658000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6718000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60549000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57282000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59791000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56430000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3465000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60549000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57282000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59791000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59895000	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13900000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	55100000	usd
CY2023Q3	brp	Business Combination And Assets Acquisitions Contingent Consideration Arrangements Liabilities Rangeof Outcomes Value High BusinessCombinationAndAssetsAcquisitionsContingentConsiderationArrangementsLiabilitiesRangeofOutcomesValueHigh	847100000	usd
	brp	Payment For Contingent Consideration Liability PaymentForContingentConsiderationLiability	61500000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	21300000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	19700000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	4700000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	306270000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-32006000	usd
CY2022Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	259368000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-46707000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	933907000	usd
	us-gaap	Profit Loss ProfitLoss	-101523000	usd
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	734676000	usd
	us-gaap	Profit Loss ProfitLoss	14725000	usd
CY2023Q3	us-gaap	Assets Assets	3423498000	usd
CY2022Q4	us-gaap	Assets Assets	3462182000	usd
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
brp-20230930_def.xml	Edgar Link	unprocessable
0001781755-23-000042-index-headers.html	Edgar Link	pending
0001781755-23-000042-index.html	Edgar Link	pending
0001781755-23-000042.txt	Edgar Link	pending
0001781755-23-000042-xbrl.zip	Edgar Link	pending
brp-20230930.htm	Edgar Link	pending
brp-20230930.xsd	Edgar Link	pending
brp-20230930_cal.xml	Edgar Link	unprocessable
brp-20230930_g1.jpg	Edgar Link	pending
exhibit-311fy2023q3.htm	Edgar Link	pending
exhibit-312fy2023q3.htm	Edgar Link	pending
exhibit-32fy2023q3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
brp-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
brp-20230930_pre.xml	Edgar Link	unprocessable
brp-20230930_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BWIN
Baldwin Insurance Group, Inc. Stock $bwin

2023 Q3 Form 10-Q Financial Statement

#000178175523000042 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWIN Baldwin Insurance Group, Inc. Stock $bwin

2023 Q3 Form 10-Q Financial Statement

#000178175523000042 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWIN
Baldwin Insurance Group, Inc. Stock $bwin